# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Shares of The Travelers Companies, Inc. (NYSE: TRV) fell sharply during Wednesday’s session following first-quarter earnings.
U.S. stocks were lower, with the Dow Jones index falling over 50 points on Wednesday.
Cantor Fitzgerald analyst Li Watsek reiterates ALX Oncology Holdings (NASDAQ:ALXO) with a Overweight.
HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates ALX Oncology Holdings (NASDAQ:ALXO) with a Buy and maintai...
The new data were presented in an oral presentation at the 2024 American Association for Cancer Research Annual Meeting. Patien...
HC Wainwright & Co. analyst Swayampakula Ramakanth maintains ALX Oncology Holdings (NASDAQ:ALXO) with a Buy and raises t...
ALX Oncology's evorpacept, poised for pivotal HER2+ gastric cancer development. Caution prevails due to sub-$100 million ma...